Starpax Biopharma

Starpax Biopharma

Current Raise

$24,000,000

Current Raise

$24,000,000

Starpax Biopharma, a Canadian biotech company, develops innovative cancer treatments using magnetically guided bacteria for targeted therapy.

Starpax Biopharma, a Canadian biotech company, develops innovative cancer treatments using magnetically guided bacteria for targeted therapy.

Overview

Starpax Biopharma is a Canadian biotechnology company specializing in innovative cancer treatments. The company develop Magnetodrones™, self-propelled bacteria designed to deliver therapies directly to tumors, and the PolarTrak® device, which enhances treatment precision using magnetic fields. Starpax operates within the biotechnology industry.

PORTFOLIO

CHECK OUT SOME MORE

CHECK OUT SOME MORE

CHECK OUT SOME MORE

CHECK OUT SOME MORE

Levolta Pharmaceuticals

Levolta Pharmaceuticals

Levolta Pharmaceuticals

$30,000,000

Levolta Pharmaceuticals

Levolta Pharmaceuticals

Levolta Pharmaceuticals

$30,000,000

Levolta Pharmaceuticals

Levolta Pharmaceuticals

Levolta Pharmaceuticals

$30,000,000

Levolta Pharmaceuticals

Levolta Pharmaceuticals

Levolta Pharmaceuticals

$30,000,000

$3,000,000

$3,000,000

$3,000,000

$3,000,000